These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 17512363

  • 1. Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease.
    Horne BD, Camp NJ, Anderson JL, Mower CP, Clarke JL, Kolek MJ, Carlquist JF, Intermountain Heart Collaborative Study Group.
    J Am Coll Cardiol; 2007 May 22; 49(20):2053-60. PubMed ID: 17512363
    [Abstract] [Full Text] [Related]

  • 2. High-resolution characterization of linkage disequilibrium structure and selection of tagging single nucleotide polymorphisms: application to the cholesteryl ester transfer protein gene.
    Horne BD, Carlquist JF, Cannon-Albright LA, Muhlestein JB, McKinney JT, Kolek MJ, Clarke JL, Anderson JL, Camp NJ.
    Ann Hum Genet; 2006 Jul 22; 70(Pt 4):524-34. PubMed ID: 16759183
    [Abstract] [Full Text] [Related]

  • 3. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S, Tiret L, Bickel C, Schlitt A, Jungmair W, Genth-Zotz S, Lubos E, Espinola-Klein C, Rupprecht HJ.
    Z Kardiol; 2004 Jul 22; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [Abstract] [Full Text] [Related]

  • 4. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S, Ademoglu E, Gurdol F, Mutlu-Turkoglu U, Bilge AK, Nisanci Y.
    Cell Biochem Funct; 2009 Oct 22; 27(7):452-7. PubMed ID: 19784962
    [Abstract] [Full Text] [Related]

  • 5. Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease.
    Baessler A, Fischer M, Mayer B, Koehler M, Wiedmann S, Stark K, Doering A, Erdmann J, Riegger G, Schunkert H, Kwitek AE, Hengstenberg C.
    Hum Mol Genet; 2007 Apr 15; 16(8):887-99. PubMed ID: 17324965
    [Abstract] [Full Text] [Related]

  • 6. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M, Inazu A, Katsuda S, Miwa K, Kawashiri MA, Nohara A, Higashikata T, Kobayashi J, Mabuchi H, Yamagishi M.
    Clin Sci (Lond); 2006 Nov 15; 111(5):325-31. PubMed ID: 16822236
    [Abstract] [Full Text] [Related]

  • 7. Cholesteryl ester transfer protein B1B1 genotype as a predictor of coronary artery disease in Taiwanese with type 2 diabetes mellitus.
    Hsieh MC, Tien KJ, Chang SJ, Lo CS, Hsin SC, Hsiao JY, Hsu SC, Liang HT, Chen HC, Shin SJ, Lin SR.
    Metabolism; 2007 Jun 15; 56(6):745-50. PubMed ID: 17512305
    [Abstract] [Full Text] [Related]

  • 8. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.
    Frisdal E, Klerkx AH, Le Goff W, Tanck MW, Lagarde JP, Jukema JW, Kastelein JJ, Chapman MJ, Guerin M.
    Hum Mol Genet; 2005 Sep 15; 14(18):2607-18. PubMed ID: 16049032
    [Abstract] [Full Text] [Related]

  • 9. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
    de Grooth GJ, Zerba KE, Huang SP, Tsuchihashi Z, Kirchgessner T, Belder R, Vishnupad P, Hu B, Klerkx AH, Zwinderman AH, Jukema JW, Sacks FM, Kastelein JJ, Kuivenhoven JA.
    J Am Coll Cardiol; 2004 Mar 03; 43(5):854-7. PubMed ID: 14998629
    [Abstract] [Full Text] [Related]

  • 10. Lack of association between the cholesteryl ester transfer protein gene--TaqIB polymorphism and coronary restenosis following percutaneous transluminal coronary angioplasty and stenting: a pilot study.
    Kaestner S, Patsouras N, Spathas DH, Flordellis CS, Manolis AS.
    Angiology; 2010 May 03; 61(4):338-43. PubMed ID: 19815603
    [Abstract] [Full Text] [Related]

  • 11. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
    Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD, Cambien F, Nicaud V, de Grooth GJ, Talmud PJ, Humphries SE, Miller GJ, Eiriksdottir G, Gudnason V, Kauma H, Kakko S, Savolainen MJ, Arca M, Montali A, Liu S, Lanz HJ, Zwinderman AH, Kuivenhoven JA, Kastelein JJ.
    Circulation; 2005 Jan 25; 111(3):278-87. PubMed ID: 15655129
    [Abstract] [Full Text] [Related]

  • 12. Common variants of Cholesteryl ester transfer protein gene and their association with lipid parameters in healthy volunteers of Tamilian population.
    Padmaja N, Ravindra Kumar M, Soya SS, Adithan C.
    Clin Chim Acta; 2007 Jan 25; 375(1-2):140-6. PubMed ID: 16890925
    [Abstract] [Full Text] [Related]

  • 13. Cholesteryl ester transfer protein gene polymorphisms are associated with coronary artery disease in Corsican population (France).
    Falchi A, Piras IS, Vona G, Amoros JP, Calo' CM, Giovannoni L, Varesi L.
    Exp Mol Pathol; 2007 Aug 25; 83(1):25-9. PubMed ID: 17275808
    [Abstract] [Full Text] [Related]

  • 14. Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin.
    Marschang P, Sandhofer A, Ritsch A, Fiŝer I, Kvas E, Patsch JR.
    J Intern Med; 2006 Aug 25; 260(2):151-9. PubMed ID: 16882279
    [Abstract] [Full Text] [Related]

  • 15. ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study.
    Girelli D, Martinelli N, Trabetti E, Olivieri O, Cavallari U, Malerba G, Busti F, Friso S, Pizzolo F, Pignatti PF, Corrocher R.
    Eur J Hum Genet; 2007 Sep 25; 15(9):959-66. PubMed ID: 17505527
    [Abstract] [Full Text] [Related]

  • 16. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF, Muhlestein JB, Horne BD, Hart NI, Bair TL, Molhuizen HO, Anderson JL.
    Am Heart J; 2003 Dec 25; 146(6):1007-14. PubMed ID: 14660992
    [Abstract] [Full Text] [Related]

  • 17. CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction.
    Regieli JJ, Jukema JW, Grobbee DE, Kastelein JJ, Kuivenhoven JA, Zwinderman AH, van der Graaf Y, Bots ML, Doevendans PA.
    Eur Heart J; 2008 Nov 25; 29(22):2792-9. PubMed ID: 18957472
    [Abstract] [Full Text] [Related]

  • 18. The differential effects of age on the association of KLOTHO gene polymorphisms with coronary artery disease.
    Rhee EJ, Oh KW, Lee WY, Kim SY, Jung CH, Kim BJ, Sung KC, Kim BS, Kang JH, Lee MH, Kim SW, Park JR.
    Metabolism; 2006 Oct 25; 55(10):1344-51. PubMed ID: 16979405
    [Abstract] [Full Text] [Related]

  • 19. Association of polymorphisms in the chemokine receptor CX3CR1 gene with coronary artery disease.
    Matzhold EM, Trummer O, Grünbacher G, Zulus B, Boehm BO, März W, Renner W.
    Cytokine; 2009 Sep 25; 47(3):224-7. PubMed ID: 19628406
    [Abstract] [Full Text] [Related]

  • 20. Association between cholesteryl ester transfer protein gene polymorphisms and variations in lipid levels in patients with coronary heart disease.
    Zheng KQ, Zhang SZ, He Y, Zhang L, Zhang KL, Huang DJ, Sun Y.
    Chin Med J (Engl); 2004 Sep 25; 117(9):1288-92. PubMed ID: 15377415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.